Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer

Tumori

Volumn 82, Issue 5, 1996, Pages 459-462

  Vaglini, Maurizio ^a   Cascinelli, Federico ^a   Chiti, Arturo ^a   Deraco, Marcello ^a   Inglese, Maria Grazia ^a   Rebuffoni, Giacomo ^a   Rizzi, Maurilia ^a   Sala, Barbara ^a   Santoro, Nicola ^a   Santinami, Mario ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

hyperthermia; pelvic recurrences; perfusion; rectal cancer; regional therapy

Indexed keywords

FLUOROURACIL; MITOMYCIN C; MITOXANTRONE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MUSCLE NECROSIS; RECTUM CANCER; REGIONAL PERFUSION; VEIN THROMBOSIS;

EID: 12644267271     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200510     Document Type: Article

References (27)

1. Aigner K.R., Kaevel K.: Pelvic stopflow infusion (PSI) and hypoxic pelvic perfusion (HPP) with mitomycin and melphalan for recurrent rectal cancer. Reg. Cancer Treat., 1: 6-11, 1994.
2. Alberto P.: Adjuvant and palliative treatments of colon cancer. Eur. J. Cancer , 28: 924-926, 1992.
3. Chang A.E., Schneider P.D., Sugarbaker P.H., Simpson C., Culnane M., Steinberg S.M.: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann. Surg., 206: 685-693, 1987.
4. Chen H.S.G., Gross J.F.: Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of response. Cancer Treat. Rep., 64: 31-40, 1980.
5. Damascelli B., Marchianò A., Spreafico C., Lutman R., Salvetti M., Bonalumi M.G., Mauri M., Garbagnati F., Del Nero A., Comeri G., Conti G., Coppoli S., Benetti G., Tralongo P., Belussi D.: Circadian continuous chemotherapy of renal cell carcinoma with an implantable programmable infusion pump. Cancer, 66: 237-241, 1990.
6. Elias D., Lasser P., Stambuck J., Lusinchi A., Souadka A., Bognel C., Rougier P., Eschwege F.: Un traitement agressif est-il justifié dans les récidives locorégionales des cancers colorectaux. Gastroenterol. Clin. Biol., 15: 3-9, 1991.
7. Heimann T.M., Szporn A., Bolnick K., Aufses A.H.: Local recurrence following surgical treatment of rectal cancer. Comparison of anterior and abdominoperineal resection. Dis. Colon Rectum, 29: 862-864, 1986.
8. Hrushesky W.J.M., Roemeling R.V., Fraley E.E., Rabatin J.T.: Circadian-based infusional chrono-chemotherapy controls progressive metastatic renal cell cancer. Semin. Surg. Oncol., 4: 110-115, 1988.
9. Kemeny N., Daly J., Reichman B., Geller N., Botet J., Oderman P.: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal cancer. A randomised trial. Ann. Intern. Med., 107: 459-465, 1987.
10. Kemeny N., Lokich J., Anderson N., Ahlgren J.D.: Recent advances in the treatment of advanced colorectal cancer. Cancer, 71: 9-18, 1993.
11. Lasser P., Elias D., Eschwege F., Bognel C., Henri-Amar M., Rougier P.: Traitement chirurgical des complications radiqués graves du grêle et du côlon-rectum. J. Chir. (Paris), 122: 27-35, 1985.
12. Malcom A.W., Perencevich N.P., Olson E.M., Hanley J.A., Chaffey J.T., Wilson R.E.: Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum. Surg. Gynecol. Obstet., 152: 131-136, 1981.
13. McGlone T.P., Bernie W.A., Elliott D.W.: Survival following extended operations for extracolonic invasion by colon cancer. Arch. Surg., 117: 595-599, 1982.
14. Müller H., Aigner K.R., Walther H.: Isolated pelvic perfusion for non resectable pelvic tumours. A pilot study. Regional Cancer Treat., 2: 92-97, 1989.
15. Pheils M.T., Chapuis P.M., Newland R.C., Colquhoyun K.: Local recurrence following curative resection for carcinoma of the rectum. Dis. Colon Rectum, 26: 98-102, 1983.
16. Pittam M.R., Thornton H., Ellis H.: Survival after extended resection for locally advanced carcinomas of the colon and rectum. Ann. R. Coll. Surg. Engl., 66: 81-84, 1984.
17. Rao A.R., Kagan A.R., Chan P.M., Gilbert H.A., Nussabaum H., Hintz B.L.: Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon. Cancer, 48: 1492-1495, 1981.
18. Santinami M., Belli F., Cascinelli N., Carraro O., Damascelli B., Deraco M., Gallino F., Manzi R., Persiani L., Santoro N., Vaglini M.: Regional perfusion in the treatment of locally advanced pelvic cancer. Regional Cancer Treat., 1: 33-38, 1994.
19. Santinami M., Belli F., Cascinelli N., Rovini D., Vaglini M.: Seven years experience with hyperthermic antiblastic perfusion in extra corporeal circulation for melanoma of extremities. J. Surg. Oncol., 42: 201-208, 1989.
20. Turner S.S., Vieira E.F., Ager P.J., Alpert S., Efron G., Ragins H., Weil P., Ghossein N.A.: Elective postoperative radiotherapy for locally advanced colorectal cancer. Cancer, 40: 105-108, 1977.
21. Urdaneta-Lafee N., Klingermann M.M., Knoweton A.H.: Evaluation of palliative irradiation in rectal carcinoma. Radiology, 104: 73-77, 1972.
22. Vaglini M., Santinami M., Nava M., Belli E, Prada A., Ammatuna M., Cascinelli N.: Hyperthermic antiblastic perfusion in extra corporeal circulation: surgical technique and results in the treatment of extremities' tumour. J. Extra-Corporeal Tech., 18: 12-20, 1986.
23. Villalon A.H., Green D.: The use of radiotherapy for pelvic recurrence following abdominoperineal resection for carcinoma of the rectum: a ten year experience. Aust. NZ J. Surg., 51: 149-151, 1981.
24. von Roemeling R., Hrushesky W.J.M.: Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer. J. Clin. Oncol., 7: 1710-1719, 1989.
25. von Roemeling R., Hrushesky W.J.M.: Circardian pattern of continuous FUDR infusion reduces toxicities. Chronobiology, pp 357-373, 1987.
26. von Roemeling R., Wick M., Rabatin J.: Circadian stage dependency of FUDR toxicity. Ann. Rev. Chronopharmacol., 3: 191-194, 1986.
27. Wile A., Smolin M.: Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. Arch. Surg., 122: 1321-1325, 1987.